Acardiac twin
Acardiac twin is a rare condition in pregnancy where one twin develops without certain vital structures, including the heart. This condition is a type of twin reversed arterial perfusion (TRAP) sequence, which is itself a subset of monochorionic twins, where the twins share the same placenta. The acardiac twin is unable to survive independently and is typically dependent on the circulatory system of the co-twin, known as the "pump twin," for blood supply.
Etiology[edit | edit source]
The exact cause of acardiac twinning is not fully understood, but it is believed to result from abnormalities in the placenta's blood vessels that lead to an abnormal blood flow between the twins. This abnormal circulation causes one twin to receive deoxygenated blood, leading to underdevelopment of essential organs, including the heart.
Pathophysiology[edit | edit source]
In the TRAP sequence, the pump twin works harder to support the circulation of both itself and the acardiac twin. This increased workload can lead to heart failure in the pump twin if left untreated. The acardiac twin, receiving the majority of its blood supply from the pump twin, develops without a fully functional heart and often other significant abnormalities, including a poorly developed or absent upper body and head.
Diagnosis[edit | edit source]
Acardiac twinning is usually diagnosed through ultrasound during pregnancy. Characteristics such as the absence of a heartbeat in one twin while observing abnormal blood flow patterns can indicate the presence of an acardiac twin.
Treatment[edit | edit source]
Treatment options are primarily focused on ensuring the health and survival of the pump twin. In some cases, intervention may be necessary to prevent heart failure in the pump twin. Options include laser surgery to ablate the blood vessels connecting the twins or other procedures to interrupt the abnormal blood flow.
Prognosis[edit | edit source]
The prognosis for the pump twin can vary widely depending on the severity of the condition and the timing and effectiveness of treatment. Without intervention, there is a high risk of morbidity and mortality for the pump twin due to the added strain on its heart.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD